Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide
US5013735A · kind A · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 1, 1990 |
| Grant date | May 7, 1991 |
| Priority date | — |
| Expiry date | Mar 1, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating a patient suffering from therapy-resistant schizophrenia by administering to the patient a therapeutically effective amount of amperozide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.